Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2004 by Bispebjerg Hospital. Recruitment status was Recruiting

First Received on September 13, 2005. Last Updated on July 23, 2007 History of Changes

Sponsor:	Bispebjerg Hospital
Information provided by:	Bispebjerg Hospital
ClinicalTrials.gov Identifier:	NCT00206921

Purpose

The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness.

Condition	Intervention
Telangiectasis Erythema	Device: Pulsed dye laser Device: Intense pulsed light

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind Primary Purpose: Treatment
Official Title:	Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness

Further study details as provided by Bispebjerg Hospital:

Study Start Date:	February 2005
Estimated Study Completion Date:	August 2005

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

18 years or older
Skin types I, II, III
No previous laser or IPL treatment for the condition

Exclusion Criteria:

Younger than 18 years old
Skin types IV, V, or VI
Pregnant or lactating women
Previous laser or IPL treatment for the condition
Recent exposure to sun or sun-beds
Treatment with oral retinoid within 6 months
Tendency to produce hypertrophic scars or keloids

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00206921

Contacts

Contact: Merete Hædersdal, MD, PhD, DrMedSci

+45 35 31 60 02

mhaedersdal@dadlnet.dk

Locations

Denmark
Bispebjerg Hospital	Recruiting
Copenhagen, Copenhagen NV, Denmark, 2400
Contact: Merete Hædersdal, MD, PhD, DrMedSci +4535316002 mhaedersdal@dadlnet.dk

Sponsors and Collaborators

Bispebjerg Hospital

Investigators

Principal Investigator:

Merete Hædersdal, MD, PhD, DrMedSci

Bispebjerg Hospital

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00206921 History of Changes
Other Study ID Numbers:	KF-01-236/04
Study First Received:	September 13, 2005
Last Updated:	July 23, 2007
Health Authority:	Denmark: The Ministry of the Interior and Health

Keywords provided by Bispebjerg Hospital:

Telangiectasia
Skin redness

Additional relevant MeSH terms:

Telangiectasis
Erythema
Vascular Diseases
Cardiovascular Diseases
Skin Diseases

ClinicalTrials.gov processed this record on February 09, 2012